Evidence map›Paper›PMID 35246160›Full record

ArticleJournal of nanobiotechnology2022

Functionalizing silica sol-gel with entrapped plant virus-based immunosorbent nanoparticles.

Matthew J McNulty, Naomi Hamada, Jesse Delzio, Liber McKee, Somen Nandi, Marjorie L Longo, Karen A McDonald

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew J McNultyDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Naomi HamadaDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Jesse DelzioDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Liber McKeeDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Somen NandiDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Marjorie L LongoDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA.
Karen A McDonaldDepartment of Chemical Engineering, University of California Davis, Davis, CA, USA. kamcdonald@ucdavis.edu.ORCID http://orcid.org/0000-0002-5145-9968

Funding

NASA 80NSSC18K1157NASA NNX16AO69ANASA NNX17AJ31GNational Science Foundation 1806366
6 · The paper itself

Abstract

Advancements in understanding and engineering of virus-based nanomaterials (VBNs) for biomedical applications motivate a need to explore the interfaces between VBNs and other biomedically-relevant chemistries and materials. While several strategies have been used to investigate some of these interfaces with promising initial results, including VBN-containing slow-release implants and VBN-activated bioceramic bone scaffolds, there remains a need to establish VBN-immobilized three dimensional materials that exhibit improved stability and diffusion characteristics for biosensing and other analyte-capture applications. Silica sol-gel chemistries have been researched for biomedical applications over several decades and are well understood; various cellular organisms and biomolecules (e.g., bacteria, algae, enzymes) have been immobilized in silica sol-gels to improve viability, activity, and form factor (i.e., ease of use). Here we present the immobilization of an antibody-binding VBN in silica sol-gel by pore confinement. We have shown that the resulting system is sufficiently diffuse to allow antibodies to migrate in and out of the matrix. We also show that the immobilized VBN is capable of antibody binding and elution functionality under different buffer conditions for multiple use cycles. The promising results of the VBN and silica sol-gel interface indicate a general applicability for VBN-based bioseparations and biosensing applications.

Indexed as

NanoparticlesPlant VirusesGelsImmunosorbentsSilica GelSilicon DioxideGelsImmunosorbentsSilica GelSilicon DioxideAntibody purificationBiosensingBioseparationsMolecular pharmingMonoclonal antibodyNanobiotechnologyPlant-made pharmaceuticalsSilica sol–gelTobamovirusVirus-based nanomaterial

Identifiers

PMID35246160
PMCPMC8895542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.